AI-generated summary
The authors randomized 38 people with chronic unilateral tinnitus and cochlear dysfunction to an 830-nm laser at 100 mW or a sham treatment, given over two weeks. They report no adverse events and some decreases in tinnitus duration and loudness matches in the laser group, but no significant change across time points on post-hoc analysis. The authors state the preliminary result is insufficient to support therapeutic efficacy.
- Participants
- 38
- Who or what was studied
- Adults with chronic unilateral tinnitus (3 months or longer) and pure-tone thresholds above 15 dB averaged at 3, 4, and 6 kHz, recruited at a tertiary-care hospital
- Wavelengths
- 830 nm
- Limits stated in the abstract
- The authors state the preliminary result is insufficient to support therapeutic efficacy, the sample was small, and the post-hoc analysis showed no significant decrease across time points.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on tinnitusjournal.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Tinnitus, Low-level laser therapy, Laser, Sham, Placebo effect. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.